-
Actavis can launch generic painkiller in May 2014 under settlement
PARSIPPANY, N.J. — Actavis and Mallinckrodt have reached a settlement concerning the former's generic version of an opioid painkiller made by the latter, Actavis said Thursday.
The companies settled patent lawsuit regarding Actavis' generic version of Mallinckrodt's Exalgo (hydromorphone hydrochloride) extended-release tablets in the 32-mg strength. The companies settled litigation regarding the 8-mg, 12-mg and 16-mg strengths last month.
-
Reports: Google Flu Trends may have overestimated epidemic
NEW YORK — Google seems to have found a nifty niche for itself with Google Flu Trends, which seeks to track the influenza outbreak by monitoring Web searches for flu-related topics, but its accuracy may be in doubt, according to published reports.
Nature reported that a comparison between data from Google Flu Trends and official surveillance data found that the Google tool had overestimated peak flu levels. Nevertheless, according to Nature, the problem is minor, and the Internet services giant will probably be able to fix it.